MELINTA THERAPEUTICS, INC. /NEW/ Contract Liability (Deferred Revenue)
MELINTA THERAPEUTICS, INC. /NEW/ had Contract Liability (Deferred Revenue) of $7.54 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2019-11-12
- 2019-09-30: Contract with Customer, Liability, Current $7.54M.
- 2019-06-30: Contract with Customer, Liability, Current $6.47M.
- 2019-03-31: Contract with Customer, Liability, Current $6.05M.
- 2018-12-31: Contract with Customer, Liability, Current $5.63M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2019-09-30 | $7.54M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $6.47M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $6.05M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $5.63M 10-Q · filed 2019-11-12 |
| 2018-09-30 | $4.29M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $3.26M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $2.86M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-14 |